1. Systemic modeling myeloma-osteoclast interactions under normoxic/hypoxic condition using a novel computational approach
   Zhiwei Ji et al, 2015, Sci Rep CrossRef
2. Hepatocellular carcinoma: Mouse models and the potential roles of proteases
   James M. Henderson et al, 2017, Cancer Letters CrossRef
3. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
   Tianyou Ma et al, 2015, Mol Med Rep CrossRef
4. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling
   BINHUI XIE et al, 2015 CrossRef
5. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK
   YAN-JIAN HU et al, 2014 CrossRef
6. B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer
   FEN LIU et al, 2015 CrossRef
7. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
   Rui Zhang et al, 2018, J Transl Med CrossRef
8. Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply
   Ken Liu et al, 2017, Clinical and Translational Gastroenterology CrossRef
9. null
   Arthur Zimmermann, 2016 CrossRef
10. null
    Arthur Zimmermann, 2016 CrossRef
11. Regulator of G-Protein Signaling-5 Is a Marker of Hepatic Stellate Cells and Expression Mediates Response to Liver Injury
    Arya J. Bahrami et al, 2014, PLoS ONE CrossRef
12. Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma
    Julia C. Engelmann et al, 2015, PLoS Comput Biol CrossRef
13. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway
    Donghua Geng et al, 2016, Tumor Biol. CrossRef
14. null
    Arthur Zimmermann, 2017 CrossRef
15. null
    Arthur Zimmermann, 2017 CrossRef
16. Quiescent hepatic stellate cells induce toxicity and sensitivity to doxorubicin in cancer cells through a caspase‐independent cell death pathway: Central role of apoptosis‐inducing factor
    Dola Das et al, 2020, J Cell Physiol CrossRef
17. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
    Qi Ruan et al, 2020, Int J Cancer CrossRef
18. Hepatic Stellate Cells and Hepatocarcinogenesis
    Anna E. Barry et al, 2020, Front. Cell Dev. Biol. CrossRef
19. In Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment
    Samantha V. Llewellyn et al, 2021, Small CrossRef
20. The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma
    Fang Wang et al, 2021, Front. Oncol. CrossRef
21. Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma
    Mengna Wu et al, 2020, CMP CrossRef
22. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
    Devaraj Ezhilarasan, 2021, J Cell Physiol CrossRef
23. Recent Perspectives on the Mechanism of Recurrence After Ablation of Hepatocellular Carcinoma: A Mini-Review
    Jianquan Yang et al, 2022, Front. Oncol. CrossRef
24. HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma
    Qi-tao Chen et al, 2022, Nat Metab CrossRef
25. Deciphering the possible reciprocal loop between hepatic stellate cells and tumor cells in the tumor microenvironment of the liver
    Devaraj Ezhilarasan et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
26. Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma
    Min Zhang et al, 2023, Experimental Cell Research CrossRef
27. Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
    Adriana G. Quiroz Reyes et al, 2023, Technol Cancer Res Treat CrossRef
28. Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells
    Liang'en Chen et al, 2024, Journal of the National Cancer Center CrossRef
29. Appraisal of folate functionalized bosutinib cubosomes against hepatic cancer cells: In-vitro, In-silico, and in-vivo pharmacokinetic study
    Raquibun Nisha et al, 2024, International Journal of Pharmaceutics CrossRef
30. The crosstalk between cholangiocytes and hepatic stellate cells promotes the progression of epithelial-mesenchymal transition and periductal fibrosis during Clonorchis sinensis infection
    Junyeong Yi et al, 2024, Parasites Vectors CrossRef
31. Fluorescence imaging sheds light on the immune evasion mechanisms of hepatic stellate cells mediated by superoxide anion
    Yuantao Mao et al, 2024, Commun Biol CrossRef